囊性纤维化气道中的缺氧与无菌性炎症:机制与潜在治疗
本综述探讨囊性纤维化(CF)气道中缺氧与无菌性中性粒细胞炎症的关系。CF呼吸疾病以慢性中性粒细胞气道炎症为特征,黏液阻塞为早期异常,常无感染证据。近期研究提示缺氧细胞死亡与无菌性中性粒细胞炎症通过IL-1信号通路关联,综述评估了缺氧作为CF致病机制的证据及潜在治疗。
要点
- CF气道早期黏液阻塞可伴中性粒细胞炎症而无感染证据。
- 缺氧细胞死亡与无菌性中性粒细胞炎症可能通过IL-1信号通路关联。
- 现有及未来治疗或可减轻缺氧驱动的无菌性炎症。
核心结论
- 缺氧可能是囊性纤维化气道无菌性中性粒细胞炎症的驱动因素,涉及IL-1信号通路。
研究设计与样本
- 综述,聚焦囊性纤维化气道缺氧与无菌性炎症的机制及潜在治疗。
主要发现
- CF呼吸疾病以慢性中性粒细胞气道炎症伴结构损伤、支气管扩张和肺功能下降为特征。
- 黏液阻塞是CF气道早期异常,常伴中性粒细胞炎症而无可检测感染。
- 近期研究提示缺氧细胞死亡与无菌性中性粒细胞炎症通过IL-1信号通路关联。
临床怎么用
- 关注CF气道黏液阻塞及缺氧相关炎症,评估IL-1通路作为潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cystic fibrosis is one of the most common autosomal recessive genetic diseases in Caucasian populations. Diagnosis via newborn screening and targeted nutritional and antibiotic therapy have improved outcomes, however respiratory failure remains the key cause of morbidity and mortality. Progressive respiratory disease in cystic fibrosis is characterised by chronic neutrophilic airway inflammation associated with structural airway damage leading to bronchiectasis and decreased lung function. Mucus obstruction is a characteristic early abnormality in the cystic fibrosis airway, associated with neutrophilic inflammation often in the absence of detectable infection. Recent studies have suggested a link between hypoxic cell death and sterile neutrophilic inflammation in cystic fibrosis and other diseases via the IL-1 signalling pathway. In this review, we consider recent evidence regarding the cellular responses to respiratory hypoxia as a potential driver of sterile neutrophilic inflammation in the lung, current knowledge on hypoxia as a pathogenic mechanism in cystic fibrosis and the potential for current and future therapies to alleviate hypoxia-driven sterile inflammation.
引用
- Montgomery ST, Mall MA, Kicic A, et al. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J. 2017. PMID: 28052955. doi:10.1183/13993003.00903-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。